UQV-58656-29480
3 vaccinations
1 coded response
13 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 633 / MO
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Dose 1 — Moderna
-
2021-02-26
Dose 2 — Moderna
-
2021-02-27
Registered in v-safe
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-27
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-02-28
- 2021-03-03
- 2021-03-07
- 2021-03-13
- 2021-03-25
- 2021-05-28
- 2021-08-29
-
2021-10-22
Dose 3 — Moderna
- 2021-10-29
- 2021-11-19
- 2021-12-03
-
2022-01-23
Survey response — 3 months, dose 3MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend schoolFree text: Tested positive for covid 1/14/2022MedDRA releases: 2024-11 · check-in free text available
- 2022-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Moderna | |
| 2 | 2021-02-26 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-27 | priority 2/3 |
Free text
Release 11 — 3 months, dose 3
Symptoms: Tested positive for covid 1/14/2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release